Sandra Tong

Statistics

Publications

Citations

173

H-Index

Active since

2014

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Daiichi Sankyo (United States)

Plexxikon (United States)

Cornell University

Sandra Tong is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, joint pathology, and colony-stimulating factor 1 signaling.

Publications per year

2014–2019

Publications

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

Heather L. Gelhorn, Sandra Tong, Kelly McQuarrie et al. · Clinical Therapeutics · 2016 · 111 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +16

The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)

Heather L. Gelhorn, Xin Ye, Rebecca M. Speck et al. · Journal of Patient-Reported Outcomes · 2019 · 29 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT).

William D. Tap, Hans Gelderblom, Silvia Stacchiotti et al. · Journal of Clinical Oncology · 2018 · 21 citations

Medicine, Oncology, Pharmacology +11

A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS).

William D. Tap, Stephen P. Anthony, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2014 · 12 citations

Medicine, Immunology, Oncology +16

1–4 of 4